Antimicrobial resistance in sexually transmitted Shigella in men who have sex with men: A systematic review
International Journal of STD & AIDS · 2023
DOI: 10.1177/09564624231154942 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of STD & AIDS, 2023. Verfasst von Holly O'Flanagan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Brighton and Sussex Medical School, Brighton, UK. Hauptthemen laut MEDLINE: Dysentery, Bacillary, Sexual and Gender Minorities, Shigella, Anti-Infective Agents. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background
Outbreaks of sexually transmitted Shigella flexneri and Shigella sonnei in men who have sex with men (MSM) are a major public health issue. While most cases can be managed conservatively, a minority require antimicrobial treatment. Recent reports have highlighted increasing antimicrobial resistant (AMR) strains of Shigella spp. in men who have sex with men. We aimed to systematically review antimicrobial resistance (and decreased antimicrobial sensitivity) in sexually transmitted shigella in men who have sex with men, focussing on macrolides, quinolones, and third generation cephalosporins.
Methods
We systematically searched 4 bibliographical databases (EMBASE, medline, EMCARE and CINAHL) from January 2011 to November 2021. We used a 2-stage process to assess eligibility: the primary author conducted an initial screen and then 3 authors conducted independent full-text reviews to determine the final eligible manuscripts. We only included manuscripts in English which included men who have sex with men with sexually transmitted shigella where data on antimicrobial resistance was available.
Results
Thirty-nine manuscripts met the inclusion criteria. A majority of the manuscripts ( N = 34) described reduced susceptibility or antimicrobial resistant to macrolides, quinolones and third generation cephalosporins in circulating strains of shigella within sexual networks of men who have sex with men. Extensively drug resistant outbreaks of shigella in men who have sex with men have been reported containing genetic markers of ceftriaxone resistance (e.g. BlaCTX-M27) where isolates also contained markers of reduced susceptibility, and antimicrobial resistant to macrolides and quinolones.
Conclusion
There is little role for macrolides, quinolones or third generation cephalosporins in the management of sexually transmitted shigella in men who have sex with men. More research is needed to develop novel strategies for shigella control in men who have sex with men, as antimicrobial options are diminishing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brighton and Sussex Medical School, Brighton, UK.
- University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
ORCID-Profile: Carrie Llewellyn, Daniel Richardson
Zitieren
APA
O'Flanagan, H., Siddiq, M., Llewellyn, C., & Richardson, D. (2023). Antimicrobial resistance in sexually transmitted Shigella in men who have sex with men: A systematic review. International Journal of STD & AIDS. https://doi.org/10.1177/09564624231154942
Vancouver
O'Flanagan H, Siddiq M, Llewellyn C, Richardson D. Antimicrobial resistance in sexually transmitted Shigella in men who have sex with men: A systematic review. International Journal of STD & AIDS. 2023. doi:10.1177/09564624231154942
BibTeX
@article{OFlanagan2023,
author = {O'Flanagan, Holly and Siddiq, Mohammed and Llewellyn, Carrie and Richardson, Daniel},
title = {Antimicrobial resistance in sexually transmitted Shigella in men who have sex with men: A systematic review},
journal = {International Journal of STD & AIDS},
year = {2023},
doi = {10.1177/09564624231154942}
}
EUVIMED